55
Pharmacodynamics Pharmacodynamics Dr Rizwan Ashraf

Lecture 1 Pharmacodynamics

Embed Size (px)

DESCRIPTION

lecture

Citation preview

Page 1: Lecture 1 Pharmacodynamics

PharmacodynamicsPharmacodynamics

Dr Rizwan Ashraf

Page 2: Lecture 1 Pharmacodynamics

Lecture Objectives Lecture Objectives To understand the basic concepts regarding pharmacodynamics To define agonist and antagonists and other terms in relation to pharmacodynamics To explain the mechanism of drug receptor interaction Define spare receptors To differentitate between different tyes of antagonism

Page 3: Lecture 1 Pharmacodynamics

WHAT IS PHARMACODYNAMICS ?

Page 4: Lecture 1 Pharmacodynamics
Page 5: Lecture 1 Pharmacodynamics

Action of a drug on the body receptor interactions, mechanisms of therapeuticdose-response phenomena, toxic action.

Page 6: Lecture 1 Pharmacodynamics

RECEPTOR INTERACTION

Page 7: Lecture 1 Pharmacodynamics

A drug will not work unless it is bound

AGREED or NOT AGREED

Page 8: Lecture 1 Pharmacodynamics

BOUND WITH WHAT ?

Page 9: Lecture 1 Pharmacodynamics

PARTICULAR CONSTITUENTS OF

CELLS & TISSUES IN ORDER TO

PRODUCE AN EFFECT

PROTEINS LIPIDS DNA

RECEPTORS ?

Page 10: Lecture 1 Pharmacodynamics

ARE THERE DRUGS THAT ACT WITHOUT ARE THERE DRUGS THAT ACT WITHOUT BEING BOUND TO ANY OF THE TISSUE BEING BOUND TO ANY OF THE TISSUE

CONSTITUENTSCONSTITUENTS

YES OR

NO

Page 11: Lecture 1 Pharmacodynamics

YESYES

OSMOTIC DIURETICSOSMOTIC PURGATIVESANTACIDSHEAVY METALS CHELATING AGENTS

Page 12: Lecture 1 Pharmacodynamics

BUTBUT

PRINCPLES REMAIN TRUE FOR GREAT MAJORITY

THAT IS _____________________

______________________________.

Page 13: Lecture 1 Pharmacodynamics

Most drugs act through Most drugs act through ReceptorsReceptors

Page 14: Lecture 1 Pharmacodynamics

Receptors Receptors

Page 15: Lecture 1 Pharmacodynamics

Drug ReceptorDrug Receptor

A macromolecular component of a cell with which a drug interacts to

produce a response

Usually a protein

Page 16: Lecture 1 Pharmacodynamics

Receptors must be biologically important molecules

Receptors must have structural features that permit drug specificity

Receptors must have a drug-binding site and a biologically active site

Page 17: Lecture 1 Pharmacodynamics

Characteristics of ReceptorsCharacteristics of Receptors

          a. specificity a. specificity

          b. selectivity of response b. selectivity of response

          c. sensitivity c. sensitivity

Page 18: Lecture 1 Pharmacodynamics

Molecules capable of serving Molecules capable of serving as as

ReceptorsReceptors

Page 19: Lecture 1 Pharmacodynamics

Enzymes

Membrane proteins

glycoproteins, lipoproteins)

Nucleic acids

Complex polysaccharides

Page 20: Lecture 1 Pharmacodynamics

Many drugs inhibit enzymes

in the patient (ACE inhibitors)

in microbes (sulfas, Penicillins)

in cancer cells (5-FU, 6-MP)

Page 21: Lecture 1 Pharmacodynamics

Types of ProteinTypes of Protein Receptors Receptors

Regulatory – mediate the action of endogenous chemicals e.g. hormones,

NT,autocoids

Enzymes – may be inhibited or activated e.g. dihydrofolate reductase

receptor for methotrexate

Transport – e.g. Na+ /K+ ATP’ase for digitalis glycosides

Structural – e.g. tubulin,receptor for colchicine

Page 22: Lecture 1 Pharmacodynamics

some drugs bind to:

the genome (cyclophosphamide)

microtubules (vincristine)

Page 23: Lecture 1 Pharmacodynamics

Non-receptor Mediated EffectsNon-receptor Mediated Effects Interaction with small molecules

(e.g. binding of heavy metals)

Interaction with enzymes (e.g. sulfonamides, digitalis)

Incorporation into a macromolecule (e.g. some anticancer agents - purine and

pyrimidine analogues)

Nonspecific effects (e.g. membrane perturbation by general anesthetics)

Page 24: Lecture 1 Pharmacodynamics

Receptor-independent drug actionsReceptor-independent drug actions Chemically reactive agents

Disinfectants

Alkylating anticancer drugs

Physically active agents

Mannitol

Hydrogen peroxide

Counterfeit biochemical constituents

5-bromouracil

Page 25: Lecture 1 Pharmacodynamics

Antagonists tend to up regulate receptors

  Receptor regulationReceptor regulation

    1.1.  HomeostasisHomeostasis     2. Up and down regulation 2. Up and down regulation

    3. Desensitization 3. Desensitization

    4. Tolerance 4. Tolerance

agonists desensitize receptors homologous

(decreased receptor number)

heterologous

(decreased signal transduction

Page 26: Lecture 1 Pharmacodynamics

PharmacodynamicsPharmacodynamics

Drug receptor interactionDrug receptor interaction

Page 27: Lecture 1 Pharmacodynamics

D + R DR Complex

Drug - Receptor BindingDrug - Receptor Binding

Affinity

Page 28: Lecture 1 Pharmacodynamics

Drug Receptor InteractionDrug Receptor Interaction

DR Complex Effect

Page 29: Lecture 1 Pharmacodynamics

Theories of the Theories of the relationship between relationship between binding and responsebinding and response

Page 30: Lecture 1 Pharmacodynamics

      a. Occupation theorya. Occupation theory

            D + R D + R DR DR RESPONSE RESPONSE:response is proportional to the fraction of occupied :response is proportional to the fraction of occupied  receptors receptors :maximal response occurs when all the receptors are occu:maximal response occurs when all the receptors are occupiedpied

Page 31: Lecture 1 Pharmacodynamics

  AriensAriens

response is proportional to the fraction of response is proportional to the fraction of occupied receptors occupied receptors ANDAND the the  intrinsic activity intrinsic activity 

Stephenson Stephenson response is aresponse is a FUNCTION FUNCTION of occupancy  of occupancy maximum response can be produced maximum response can be produced  WITHOUT 100% occupation, WITHOUT 100% occupation, 

i.e. tissues havei.e. tissues have  spare receptorsspare receptors

Page 32: Lecture 1 Pharmacodynamics

BIOLOGICAL STIMULUSBIOLOGICAL STIMULUS

PERCENT RECEPTOR OCCUPANCYPERCENT RECEPTOR OCCUPANCY

0%0% 100%100%

BIOLOGICAL RESPONSEBIOLOGICAL RESPONSE RECEPTOR RESERVERECEPTOR RESERVETRETHOLDTRETHOLD

0%0% 100%100%

Max EffectMax EffectThreshold EffectThreshold Effect

Schematic representation of the relationship between threshold, receptor Schematic representation of the relationship between threshold, receptor reserve, receptor occupancy, biological stimulus and biological responsereserve, receptor occupancy, biological stimulus and biological response

Page 33: Lecture 1 Pharmacodynamics

Receptors are said to be spare

for a given pharmacological response

when the maximal response can be elicited

by an agonist at a concentration that does

not result in occupancy of the full complement

of available receptors

Page 34: Lecture 1 Pharmacodynamics

Spare receptors More receptors available than needed

to elicit maximum responseallow maximal response without total receptor occupancy – increase sensitivity of the system

Agonist has to bind only a portion of

receptors for full effect

Page 35: Lecture 1 Pharmacodynamics
Page 36: Lecture 1 Pharmacodynamics

Some terminologies regarding Some terminologies regarding drug receptor interactiondrug receptor interaction

Affinity

Efficacy

Potency

Ligand

Page 37: Lecture 1 Pharmacodynamics

Affinity: measure of propensity of a drug to bind receptor; the attractiveness of drug and

receptor

Efficacy: Potential maximum therapeutic response

that a drug can produce.

Potency: Amount of drug needed to produce an

effect.

Page 38: Lecture 1 Pharmacodynamics

POTENCY

OR

EFFICACY

Which one is important while selecting a drug for therapy ?

Page 39: Lecture 1 Pharmacodynamics

Ligand:

Molecules that binds to a receptor

Page 40: Lecture 1 Pharmacodynamics

Classification of Ligands Classification of Ligands

a.a.    agonist agonist

b.  partial agonistb.  partial agonist

c.  antagonist c.  antagonist

pharmacological vs. physiological vs. chemical pharmacological vs. physiological vs. chemical

              pharmacological antagonistspharmacological antagonists

              - - competitive competitive

                       surmountable surmountable

                  - - noncompetitive noncompetitive

Page 41: Lecture 1 Pharmacodynamics

AGONIST

Page 42: Lecture 1 Pharmacodynamics

AgonistsAgonists Drugs that cause a response Drugs that interact with and activate receptors; They possess both affinity and efficacyTypes Full agonists

An agonist with maximal efficacy (response) has affinity plus intrinsic activity Partial agonists

An agonist with less then maximal efficacy has affinity and less intrinsic activity

Page 43: Lecture 1 Pharmacodynamics

Agonists differing in potency and maximum efficacy

Page 44: Lecture 1 Pharmacodynamics

Response

Dose

Full agonist

Partial agonist

Agonist Dose Response Curves

Page 45: Lecture 1 Pharmacodynamics

[D] (concentration units)

% M

axim

al E

ffec

t

0.01 0.10 1.00 10.00 100.00 1000.000.0

0.2

0.4

0.6

0.8

1.0

Partial agonist

Full Agonist

Partial agonist

PARTIAL AGONISTS - EFFICACYEven though drugs may occupy the same # of receptors, the magnitude

of their effects may differ.

Page 46: Lecture 1 Pharmacodynamics

AntagonistsAntagonists Interact with the receptor but do NOT change the receptor

Have affinity but NO efficacy

Block the action of other drugs

Effect only observed in presence of agonist

Page 47: Lecture 1 Pharmacodynamics

Types of AntagonistsTypes of Antagonists

Competitive

(Surmountable)decrease apparent

Potency

Noncompetitivedecrease

apparent maximum

efficacy

Page 48: Lecture 1 Pharmacodynamics

Competitive AntagonistCompetitive Antagonist

competes with ________for receptor

surmountable with increasing agonist concentration

displaces agonist dose response curve to the ___________(dextral shift)

reduces the apparent affinity of the __________.

Page 49: Lecture 1 Pharmacodynamics

Noncompetitive AntagonistNoncompetitive Antagonist

drug binds to receptor and stays boundirreversible – does not let go of receptor

produces slight dextral shift in the agonist DR curve in the low concentration range

but, as more and more receptors are bound (and essentially destroyed),

the agonist drug becomes incapable of eliciting a maximal effect

Page 50: Lecture 1 Pharmacodynamics

AGONIST VS ANTAGONIST

Page 51: Lecture 1 Pharmacodynamics
Page 52: Lecture 1 Pharmacodynamics

What happen when you increase agonist concentration even higher

Page 53: Lecture 1 Pharmacodynamics

How do non competitive antagonist affect receptor function

Page 54: Lecture 1 Pharmacodynamics
Page 55: Lecture 1 Pharmacodynamics

Summary (T or F)

Pharmacodynamics is the study of absorption, distribution, metabolism and elimination of drug. Some drugs can act without binding to a receptor spare receptors allow maximum response without full receptor occupancy Efficacy is the amount of drug needed to produce an effect. Affinity is the attractiveness between 2 drug molecules. Agonist are the drugs that block the response. Partial agonist has affinity and maximum efficacy. Antagonist has efficacy but no affinity. Competitive antagonist decreases potency Non competitive antagonist decreases efficacy